News Headlines

Display #
New York county sues Purdue, J&J over opioid marketing
AstraZeneca Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business
New FDA Head Discusses First Order of Business
X-Chem, Vertex Enter into Collaboration
Unlocking the Mystery of Multiple Sclerosis With Tech
Novelion CEO quits Novo Nordisk board due to NASH conflict
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
Durvalumab reduces risk of death from lung cancer
Migraine drug meets main late-stage studies goal
WHO wants transparency, market revamp for fairer drug pricing therape
Sangamo Therapeutics and Pfizer announce collaboration for Hemophilia A gene therapy
Discovery Worldwide Names Matt Silver to SVP, Strategy, Engagement and Analytics
Symphony Health Launches Audience & Media Division
WHO wants transparency, market revamp for fairer drug pricing
U.S. candymakers band together to reduce calories
Alzheimer's experts call for changes in FDA drug approval standards
Imfinzi significantly reduces the risk of disease worsening or death in the Phase III PACIFIC trial for Stage III unresectable lung cancer
Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options
SoCal’s Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results
Key AstraZeneca drug shown to reduce risk of death from lung cancer
Lilly migraine treatment meets main goal in late-stage studies
Vaccine alliance says 300,000 doses of Merck’s Ebola shot available for emergencies
Pfizer strikes deal with Sangamo, broadening hemophilia pipeline
FDA approves Merck combo for lung cancer
In Europe, U.S., modern AIDS drugs add extra 10 years of life expectancy
SERMO unveils first global physician-to-physician drug ratings tool
GSK escapes Advair hit for now as second generic bid fails
Daiichi Sankyo Abandons 6 Clinical Programs in Quarterly Update
Teva Reports First Quarter 2017 Financial Results
Novo Nordisk bets on new obesity drug recipes